Si prevede che il mercato dello screening delle alterazioni endocrine raggiungerà i 153,30 milioni di dollari entro il 2028 rispetto ai 126,53 milioni di dollari del 2021; si prevede che crescerà a un CAGR del 2,8% tra il 2021 e il 2028.
Molte sostanze chimiche, sia naturali che artificiali, hanno il potenziale di imitare o interferire con il sistema endocrino, che regola gli ormoni del corpo. Queste sostanze chimiche, note come interferenti endocrini, sono state collegate a disturbi dello sviluppo, riproduttivi, cerebrali, immunologici e di altro tipo. Gli interferenti endocrini possono essere presenti in una varietà di articoli comuni, come alcune bottiglie e contenitori di plastica, rivestimenti metallici per lattine per alimenti, detergenti, ritardanti di fiamma, alimenti, giocattoli, cosmetici e pesticidi. Pesticidi, sostanze chimiche e tossine ambientali vengono esaminati utilizzando un metodo a due livelli per il loro potenziale effetto sui sistemi degli estrogeni, degli androgeni e degli ormoni tiroidei mediante lo screening degli interferenti endocrini.
Approfondimenti strategici
La crescita del mercato dello screening delle alterazioni endocrine è attribuita alla crescente ricerca nel settore delle biotecnologie e alla crescente prevalenza dei disturbi endocrini. Tuttavia, il costo elevato della tecnologia di screening ostacola la crescita del mercato.
Regioni redditizie nel mercato dello screening delle alterazioni endocrine
Approfondimenti di mercato
La crescente prevalenza dei disturbi endocrini guida il mercato dello screening delle alterazioni endocrine
La crescente prevalenza dei disturbi endocrini guida il mercato dello screening delle alterazioni endocrine
Acromegalia (sovrapproduzione dell'ormone della crescita), obesità, sindrome metabolica, ridotta glicemia a digiuno, ridotta tolleranza al glucosio, osteoporosi, osteopenia, ipovitaminosi D lieve-moderata, disfunzione erettile, dislipidemia e tiroidite sono tra i disturbi endocrini che hanno una prevalenza collettiva di almeno il 5% tra gli adulti negli Stati Uniti. Di queste condizioni, i maschi hanno la più alta incidenza di disfunzione erettile, mentre le femmine hanno la più alta incidenza di osteopenia/osteoporosi. Il diabete mellito nei bambini e l’adenoma ipofisario sono le condizioni meno comuni, che colpiscono meno dell’1% della popolazione statunitense. Il carcinoma surrenale, il feocromocitoma e gli adenomi ipofisari sono le condizioni con l'incidenza più bassa. L’iperparatiroidismo e i disturbi della tiroide sono più comuni nelle donne. Il diabete mellito è più diffuso tra le minoranze etniche. Le malattie endocrine e metaboliche sono tra i disturbi umani moderni più comuni, in particolare negli Stati Uniti e in altri paesi che implementano ampi programmi nutrizionali e di screening per individui ad alto rischio. Disturbi endocrini come iperparatiroidismo, ipogonadismo primario e secondario, deficit di GH e ipotiroidismo possono portare ad altri disturbi, come la malattia metabolica ossea e il diabete mellito. Pertanto, la crescente prevalenza e incidenza di tali condizioni spinge la domanda di prodotti per lo screening degli interferenti endocrini.
Approfondimenti basati sul tipo di test
L'interferente endocrino Il mercato dello screening, in base al tipo di test, è suddiviso in in vitro e in vivo. Il segmento in vitro ha guidato il mercato nel 2021, contribuendo a una quota di mercato del 64,45% e si prevede che manterrà la sua posizione dominante durante il periodo di previsione per rappresentare una quota di mercato del 65,73% delle entrate complessive generate nel 2028.
Mercato dello screening delle alterazioni endocrine, per tipo di analisi: – 2021 e 2028
Approfondimenti basati sull'applicazione
Per applicazione, il mercato dello screening delle alterazioni endocrine è biforcato in materiali naturali e materiali sintetici. Nel 2021, il segmento dei materiali naturali deteneva una quota maggiore del mercato. Inoltre, si prevede che il mercato per lo stesso segmento crescerà a un CAGR più rapido del 3,1% nel periodo dal 2021 al 2028.
Fonte di approfondimenti basati sui rifiuti
Il mercato dello screening degli interferenti endocrini, per fonte di rifiuti, è segmentato in incenerimento e discarica, deflusso agricolo, effluenti industriali e municipali, effluenti delle cartiere, prodotti di consumo e altri. Nel 2021, il segmento dell’incenerimento e delle discariche deteneva la quota maggiore del mercato. Inoltre, si prevede che il mercato per lo stesso segmento crescerà al CAGR più veloce del 3,5% nel periodo dal 2021 al 2028.
Approfondimenti basati sul metodo
Il mercato dello screening delle alterazioni endocrine, in base al metodo, è segmentato in transattivazione del recettore degli estrogeni (ER), transattivazione del recettore degli androgeni (AR), modulazione del recettore degli androgeni (AR), legame del recettore alfa degli estrogeni (ER), legame del recettore beta degli estrogeni (ER) , legame con il recettore degli androgeni (AR), steroidogenesi, test dell'aromatasi e altri. Nel 2021, il segmento della transattivazione del recettore degli estrogeni (ER) deteneva la quota maggiore del mercato. Inoltre, si prevede che il mercato per lo stesso segmento crescerà al tasso CAGR più veloce del 3,7% dal 2021 al 2028.
Approfondimenti basati sull'utente finale
Il mercato dello screening degli interferenti endocrini, in base all'uso finale, è segmentato in aziende farmaceutiche e biofarmaceutiche, aziende di cosmetici e prodotti per la casa, industria alimentare e industria chimica. Nel 2021, il segmento delle aziende farmaceutiche e biofarmaceutiche deteneva la quota maggiore del mercato. Inoltre, si prevede che il mercato per lo stesso segmento crescerà al CAGR più rapido del 3,3% nel periodo dal 2021 al 2028.
Il lancio e l'approvazione dei prodotti sono strategie comunemente adottate dalle aziende per espandere la propria presenza globale e il portafoglio di prodotti. Inoltre, gli operatori del mercato dello screening delle alterazioni endocrine si concentrano sulla strategia di partnership per ampliare la propria clientela, che, a sua volta, consente loro di mantenere il proprio marchio in tutto il mondo.
Il rapporto segmenta il mercato dello screening delle alterazioni endocrine come segue
Mercato dello screening delle alterazioni endocrine: per tipo di analisi
- In-Vitro
- In-Vivo
Mercato dello screening delle alterazioni endocrine - per applicazione
- Materiali naturali
- Materiali sintetici
Mercato dello screening delle alterazioni endocrine: per fonte di rifiuto
- incenerimento e discarica
- deflusso agricolo
- effluenti industriali e municipali
- effluenti da cartiere
- Prodotti di consumo
- Altro
Mercato dello screening delle alterazioni endocrine: per metodo
- Transattivazione del recettore degli estrogeni (ER)
- Transattivazione del recettore degli androgeni (AR)
- Modulazione del recettore degli androgeni (AR)
- Legame con il recettore alfa degli estrogeni (ER-alfa)
- Legame con il recettore degli estrogeni beta (ER-beta)
- Legame con il recettore degli androgeni (AR)
- Steroidogenesi
- Saggio dell'aromatasi
- Altri
Mercato dello screening delle alterazioni endocrine - per utente finale
- Aziende farmaceutiche e biofarmaceutiche
- Industria chimica
- Industria alimentare
- Aziende di cosmetici e prodotti per la casa
- li>
Mercato dello screening delle alterazioni endocrine - per area geografica
- Nord America
- Stati Uniti
- Canada
- Messico
< li>Europa - Regno Unito
- Germania
- Francia
- Italia
- Spagna
- Resto dell'Europa
- Asia Pacifico
- Cina
- Giappone
- India
- Australia
- Corea del Sud
- Resto dell'Asia Pacifico
- Medio Oriente e Africa
- Emirati Arabi Uniti
- Arabia Saudita
- Sudafrica
- Resto del Medio Oriente e dell'Africa
- America meridionale e centrale
- < li>Brasile
- Argentina
- Resto dell'America centrale e meridionale
Profili aziendali
< p>- CREATIVE BIOARRAY
- XENOMETRIX AG
- CHARLES RIVER LABORATORIES, INC.
- EUROFINS SCIENTIFIC Ltd.< /li>
- SMITHERS
- SGS SA
- JRF GLOBAL
- MéRIEUX NUTRISCIENCES
- ALPHA ANALYTICAL INC.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Many chemicals, both natural and man-made, can imitate or interfere with the endocrine system, which regulates the body's hormones. These chemicals, known as endocrine disruptors, have been related to developmental, reproductive, cognitive, immunological, and other issues. Many ordinary products include endocrine disruptors, such as some plastic bottles and containers, metal food can liners, detergents, flame retardants, food, toys, cosmetics, and pesticides. Some hormone-disrupting compounds take a long time to degrade in the environment. As a result of this trait, they can become dangerous over time. Pesticides, chemicals, and environmental toxins are screened using a two-tiered method for their potential effect on the estrogen, androgen, and thyroid hormone systems by the endocrine disruptor screening.
The growth of the endocrine disruption screening market is mainly attributed to factors such as the increasing prevalence of endocrine disorders coupled with rising incidence of diabetes. However, the high cost of screening technology and devices is hindering the market growth. In July 2021, DDA platform, the division of Creative Bioarray, launched a wide range of genotoxicity testing services (non-GLP) into the service segment of in vitro toxicity services which is contributing to the growth of the target market. Such strategic steps are also projected to drive the market growth.
The Asia Pacific region is expected to be the fastest-growing region among all other regions. The market is this region is expected to grow significantly in countries such as China, Japan, South Korea, and India. The growth of the market in this region is expected to grow at a faster pace owing to factors such as high prevalence of this hormonal changes, and the rise in healthcare awareness. Additionally, developing healthcare infrastructure and increasing investments are projected to drive the Asia Pacific endocrine disruption screening market during the forecast period.
Regulatory agencies throughout the world are grappling with the task of assessing the hazards and dangers to human and ecosystem health that may come from exposure to substances that disrupt the normal functioning of endocrine systems. The rapidly rising number of compounds in commerce, along with the dependence on conventional, expensive animal tests for hazard assessment – frequently with insufficient sensitivity to many critical processes of endocrine disruption – poses persistent problems for chemical management. As a result, there are only a few compounds for which there is enough evidence to determine whether there is endocrine toxicity, and hence only a few substances with full hazard categorization. To address this issue, regulatory assessment of endocrine disrupting chemicals (EDCs) is benefiting from a toxicology revolution focused on New Approach Methodologies (NAMs) to more rapidly identify, prioritize, and assess the potential risks from chemical exposure using novel, more efficient, and mechanistically driven methodologies, and tools.
The global endocrine disruption screening market is expected to reach US$ 153.30 million by 2028 from US$ 126.53 million in 2021. The market is estimated to grow with a CAGR of 2.8% from 2021-2028.
The List of Companies - Endocrine Disruption Screening Market
- CREATIVE BIOARRAY
- XENOMETRIX AG
- CHARLES RIVER
- EUROFINS SCIENTIFIC
- SMITHERS
- SGS SA
- JRF GLOBAL
- MéRIEUX NUTRISCIENCES
- ALPHA ANALYTICAL
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Nov 2021
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Nov 2021
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Nov 2021
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Nov 2021
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Nov 2021
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Nov 2021
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Nov 2021
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)